AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
On May 6, 2025, Sanofi's trading volume reached 1.88 billion, marking a significant 100.07% increase from the previous day. This surge placed
at the 470th position in the daily stock market rankings. However, the stock price of Sanofi-aventis (SNY) fell by 2.64%, marking the second consecutive day of decline, with a total decrease of 4.13% over the past two days.Sanofi, a leading pharmaceutical company, announced a dividend increase to €3.92 per share during its Annual General Meeting. This move is expected to bolster investor confidence in the company's financial health and future prospects.
In 2024, Sanofi reported a revenue of 44.29 billion, reflecting a 7.73% increase from the previous year's 41.11 billion. The company's earnings also saw a notable rise, reaching 5.56 billion, up by 2.96%. These financial results underscore Sanofi's strong performance and growth trajectory.
Recursion Pharmaceuticals reported a $7 million milestone payment from Sanofi, bringing the total partnership inflows to $130 million. This development highlights the ongoing collaboration between the two companies and the potential for future clinical advancements.
Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.

Dec.29 2025

Dec.26 2025

Dec.26 2025

Dec.25 2025

Dec.24 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet